Currently, less than 5% of government funding for medical research goes into surgery
One of only seven Royal College of Surgeons specialist trial centres across the whole of the UK, SITU is a collaboration between the Nuffield Department of Surgical Sciences (NDS) and the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS). We have an extensive portfolio of surgical trials and welcome expressions of interest from potential new researchers.
More information about NDS SITU and our work within surgical research can be found by following the links below.
About Us
Our Surgical Trials
Work With Us
.
NDS SITU Mission Statement |
|
NDS SITU Core Principle |
We design, develop and deliver high quality, innovative and impactful surgical trials using novel methodologies and technologies to shape the future of trial-based research and pave the way for evolution in clinical practice. | We have established a nurturing environment that promotes continuous learning and development for all of our staff and collaborators and together we have an unfaltering dedication to implementing meaningful improvements in patient care and experience. |
Latest publications
-
Perspectives on technology - prostate cancer: is local anaesthetic transperineal prostate biopsy really better than transrectal biopsy?
Journal article
Berridge C. et al, (2024), BJU Int
-
New role of fat-free mass in cancer risk linked with genetic predisposition.
Journal article
Harris BHL. et al, (2024), Sci Rep, 14
-
Percutaneous interstitial brachytherapy ablation for targeting oligometastatic gynecologic cancers.
Journal article
Lai TS. et al, (2024), Brachytherapy
-
Intra-prostatic tumour evolution, steps in metastatic spread and histogenomic associations revealed by integration of multi-region whole-genome sequencing with histopathological features.
Journal article
Rao S. et al, (2024), Genome Med, 16